# THNR holdings: all 21 positions

> All 21 THNR holdings with weights, as of Oct 14, 2026. The top 3 are LLY 10.93%, NVO 8.80% and AMGN 6.04%. Download the full list as a CSV.

Data as of Oct 14, 2026. Rebuilt every trading night.

THNR held 21 positions as of Oct 14, 2026. Eli Lilly & Co is the largest at 10.93%; the top 10 are 64.7% of the fund.

Source: Amplify (https://amplifyetfs.com/THNR-holdings/).

| # | Holding | Ticker | Weight |
| --- | --- | --- | --- |
| 1 | Eli Lilly & Co | LLY | 10.93% |
| 2 | Novo Nordisk A/S | NVO | 8.80% |
| 3 | Amgen Inc | AMGN | 6.04% |
| 4 | AbbVie Inc | ABBV | 5.82% |
| 5 | Pfizer Inc | PFE | 5.72% |
| 6 | Roche Holding AG |  | 5.63% |
| 7 | Gilead Sciences Inc | GILD | 5.59% |
| 8 | AstraZeneca PLC | AZN | 5.50% |
| 9 | Merck & Co Inc | MRK | 5.37% |
| 10 | Regeneron Pharmaceuticals Inc | REGN | 5.32% |
| 11 | CSPC Pharmaceutical Group Ltd |  | 5.29% |
| 12 | Innovent Biologics Inc |  | 4.94% |
| 13 | Chugai Pharmaceutical Co Ltd |  | 4.79% |
| 14 | Viking Therapeutics Inc | VKTX | 4.18% |
| 15 | Arrowhead Pharmaceuticals Inc | ARWR | 3.72% |
| 16 | Zealand Pharma A/S |  | 3.37% |
| 17 | Hanmi Pharm Co Ltd |  | 3.00% |
| 18 | Structure Therapeutics Inc | GPCR | 2.40% |
| 19 | Jiangsu Hengrui Pharmaceuticals Co Ltd |  | 2.28% |
| 20 | Kailera Therapeutics Inc | KLRA | 0.96% |
| 21 | Invesco Government & Agency Portfolio 12/31/2031 | AGPXX | 0.26% |
| | Cash & Other | | 0.11% |
| | Cash and other net assets | | −0.02% |

The largest 21 of 21 positions are shown. All of them: https://etfiq.com/funds/thnr/holdings/thnr-holdings.csv (CSV) or https://etfiq.com/data/books/thnr.json (JSON).

Fund page: https://etfiq.com/funds/thnr

Cite: ETFIQ, Holdings of THNR, data as of Oct 14, 2026. https://etfiq.com/funds/thnr/holdings/